Sepsis - it is all about the platelets

Area of Science:

• Hematology
• Infectious Diseases
• Critical Care Medicine

Background:

• Sepsis is frequently accompanied by thrombocytopenia, a condition characterized by low platelet counts.
• The severity of thrombocytopenia in sepsis correlates with patient mortality.
• This thrombocytopenia is a hallmark of sepsis-associated coagulopathy, specifically disseminated intravascular coagulation (DIC).

Purpose of the Study:

• To review the mechanisms by which pathogens activate platelets during sepsis.
• To examine the evidence supporting the use of anti-platelet agents in managing sepsis.
• To understand the role of platelet activation in sepsis-induced DIC and multi-organ failure.

Main Methods:

• Literature review of studies on pathogen-platelet interactions in sepsis.
• Analysis of research on the pathogenesis of sepsis-associated coagulopathy.
• Evaluation of clinical and preclinical data on anti-platelet therapies in sepsis models.

Main Results:

• Many bacterial and viral pathogens directly activate platelets.
• Pathogen-induced platelet activation contributes to systemic thrombosis.
• This process is implicated in driving the multi-organ failure characteristic of DIC in sepsis.

Conclusions:

• Pathogen-mediated platelet activation is a key mechanism in sepsis-induced DIC.
• Anti-platelet agents represent a potential therapeutic strategy for sepsis management.
• Further research is warranted to validate the efficacy of anti-platelet therapies in clinical sepsis settings.